Patents by Inventor Marc Chapdelaine

Marc Chapdelaine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic quinolone compounds with 5-ht-antagonistic properties
    Publication number: 20050085457
    Abstract: Provided herein is a compound having the formula (I) (R2 is typically a tertiary nitrogen atom, being either alkyl-substituted or member of q heterocyclic ring; R7 is typically a monocyclic or bicyclic aromatic ring or a heterocyclic ring) wherein said compounds are useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT1B and 5HT1D antagonists.
    Type: Application
    Filed: November 1, 2002
    Publication date: April 21, 2005
    Inventors: Markus Haeberlein, Daniel Sohn, Marc Chapdelaine, Timothy Davenport, Carey Horchler, Edward Pierson, John McCauley
  • Therapeutic heterocyclic compounds
    Publication number: 20050009818
    Abstract: Provided herein is a compound having the formula (I): Wherein said compounds are useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT1B and 5HT1D antagonists.
    Type: Application
    Filed: July 12, 2004
    Publication date: January 13, 2005
    Inventors: Edward Pierson, Daniel Sohn, Markus Haeberlein, Timothy Davenport, Marc Chapdelaine, Carey Horchler, John McCauley
  • N-type calcium channel antagonists for the treatment of pain
    Patent number: 6841680
    Abstract: Compounds having selective action at neuronal N-type calcium channels useful for the treatment of pain in accord with the following structural diagram, wherein R1, R2 and R3 are a variety of groups as defined in the specification.
    Type: Grant
    Filed: October 31, 2001
    Date of Patent: January 11, 2005
    Assignee: AstraZeneca AB
    Inventors: Marc Chapdelaine, Lucius Kemp, John McCauley
  • N-type calcium channel antagonists for the treatment of pain
    Patent number: 6815447
    Abstract: Compounds useful for the treatment of pain in accord with the following structural diagram, wherein R1, R2 and R3 are any of a number of groups as defined in the specification and pharmaceutical compositions and methods of treatment utilising such compounds.
    Type: Grant
    Filed: October 2, 2003
    Date of Patent: November 9, 2004
    Assignee: Astrazeneca AB
    Inventors: Bipinchandra Chaudhari, Marc Chapdelaine, Greg Hostetler, Lucius Kemp, John McCauley
  • Therapeutic heterocyclic compounds
    Patent number: 6812225
    Abstract: Provided herein is a compound having the formula (I): Wherein said compounds are useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT1B and 5HT1D antagonists.
    Type: Grant
    Filed: January 16, 2002
    Date of Patent: November 2, 2004
    Assignee: AstraZeneca AB
    Inventors: Edward Pierson, Daniel Sohn, Markus Haeberlein, Timothy Davenport, Marc Chapdelaine, Carey Horchler, John P. McCauley
  • Therapeutic chroman compounds
    Publication number: 20040110745
    Abstract: Provided herein is a compound represented by the Formula (I) wherein said compounds are useful for the treatment of migraine. Also provided are processes for the preparation of compounds of Formula (I) and intermediates.
    Type: Application
    Filed: July 16, 2003
    Publication date: June 10, 2004
    Inventors: Marc Chapdelaine, Timothy Davenport, Markus Haeberlein, Carey Horchler, John McCauley, Edward Pierson, Daniel Sohn
  • Therapeutic chromone compounds
    Publication number: 20040087575
    Abstract: Provided herein is a compound of the formula (I) wherein said compound is useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating, disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT1B antagonists. Also provided herein are processes for making compounds of Formula (I) and intermediate compounds.
    Type: Application
    Filed: July 16, 2003
    Publication date: May 6, 2004
    Inventors: Marc Chapdelaine, Timothy Davenport, Markus Haeberlein, Carey Horchler, John McCauley, Edward Pierson, Daniel Sohn
  • Therapeutic heterocyclic compounds
    Publication number: 20040082591
    Abstract: Provided herein is a compound having the formula (I) wherein said compounds are useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT1B and 5HT1D antagonists.
    Type: Application
    Filed: July 16, 2003
    Publication date: April 29, 2004
    Inventors: Marc Chapdelaine, Timothy Davenport, Markus Haeberlein, Carey Horchler, John McCauley, Edward Pierson, Daniel Sohn
  • N-type calcium channel antagonists for the treatment of pain
    Publication number: 20040077644
    Abstract: Compounds useful for the treatment of pain in accord with the following structural diagram, 1
    Type: Application
    Filed: November 3, 2003
    Publication date: April 22, 2004
    Inventors: Marc Chapdelaine, Lucius Kemp, John McCauley
  • N-type calcium channel antagonists for the treatment of pain
    Publication number: 20040058945
    Abstract: Compounds useful for the treatment of pain in accord with the following structural diagram, 1
    Type: Application
    Filed: October 2, 2003
    Publication date: March 25, 2004
    Inventors: Bipinchandra Chaudhari, Marc Chapdelaine, Greg Hostetler, Lucius Kemp, John McCauley
  • N-type calcium channel antagonists for the treatment of pain
    Publication number: 20040053965
    Abstract: Compounds having selective action at neuronal N-type calcium channels useful for the treatment of pain in accord with the following structural diagram, 1
    Type: Application
    Filed: October 15, 2003
    Publication date: March 18, 2004
    Inventors: Marc Chapdelaine, Lucius Kemp, John McCauley
  • N-type calcium channel antagonists for the treatment of pain
    Publication number: 20040053964
    Abstract: Compounds useful for the treatment of pain in accord with the following structural diagram, 1
    Type: Application
    Filed: September 29, 2003
    Publication date: March 18, 2004
    Inventors: Glen Ernst, Marc Chapdelaine, Dannielle Kissel, Greg Hostetler, John McCauley
  • Therapeutic heterocyclic compounds
    Publication number: 20030013708
    Abstract: Provided herein is a compound having the formula (I): 1
    Type: Application
    Filed: January 16, 2002
    Publication date: January 16, 2003
    Inventors: Edward Pierson, Daniel Sohn, Markus Haeberlein, Timothy Davenport, Marc Chapdelaine, Carey Horchler, John P. McCauley